UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Uroplasty, Inc. Regarding t...
December 24 2014 - 12:19PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Uroplasty, Inc. (“Uroplasty” or “the Company”) (NasdaqCM: UPI) for
possible breaches of fiduciary duty and other violations of state
law in connection with the sale of the Company to Vision-Sciences,
Inc. (NasdaqCM: VSCI).
Click here to learn more about the investigation:
http://zlk.9nl.com/uroplasty.
Under the terms of the transaction, Uroplasty shareholders will
receive 3.6331 shares of Vision-Sciences common stock for each
share of Uroplasty stock they own. The investigation concerns
whether the Board of Uroplasty breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether
Vision-Sciences, Inc. is underpaying for Uroplasty shares. The
combined company will conduct business as Cogentix Medical, Inc.
(Nasaq: CGNT).
If you own Uroplasty common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit http://zlk.9nl.com/uroplasty.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
(MM) (NASDAQ:UPI)
Historical Stock Chart
From Aug 2024 to Sep 2024
(MM) (NASDAQ:UPI)
Historical Stock Chart
From Sep 2023 to Sep 2024